rHep B vaccine (BTG)

Hepatitis B is one of a few known non-retroviralviruses which employ reverse transcriptionas a part of its replication process. (HIV, a completely unrelated virus, also uses reverse transcription, but it is a retrovirus.) HBV invades the cell by binding to surface receptor and become internalized. The viral core particles then migrate to the hepatocyte nucleus and the partially double-stranded, relaxed circular genomes (RC-DNA) are repaired to form a covalently closed circular DNA (cccDNA), which is the template for viral genomic and sub-genomic RNAs by cellular RNA polymerase II. Of these, the pregenomic RNA (pgRNA is selectively packaged into progeny capsids and is then reverse-transcribed into new RC-DNA. The core can either bud into the endoplasmic reticulum to be enveloped or exported from the cell or recycled back into the genome for conversion to cccDNA.
| Cat No.: | PTAB1430017 |
| Product Name: | rHep B vaccine (BTG) |
| Type: | Protein |
| Property: | |
| Origin: | |
| Source: | mouse |
| Application: | Direct ELISA, Western Blot, Immuneprecipitation, immunohistochemistry. |
| Formulation: | |
| Purity: | >95% by SDS-PAGE gel |
| Storage: | Avoid repeated freeze-thaw cycles. 12 months at -20 C to -80 C. 1 month at 2 C to 8 C. |
| Limitation: | |
| Note: |

